Long Focus Capital Management’s BioVie BIVI Stock Holding History

Long Focus Capital Management’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-200	Closed	-$68.2K	–	113
2023 Q3	$68.2K	Hold	200	–	–	﹤0.01%	111
2023 Q2	$86.2K	Hold	200	–	–	﹤0.01%	109
2023 Q1	$162K	Hold	200	–	–	0.01%	104
2022 Q4	$155K	Hold	200	–	–	0.01%	102
2022 Q3	$50K	Hold	200	–	–	﹤0.01%	104
2022 Q2	$29K	Hold	200	–	–	﹤0.01%	112
2022 Q1	$94K	Hold	200	–	–	0.01%	104
2021 Q4	$90K	Buy	+200	New	+$116K	0.01%	99

Other funds holding BIVI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Long Focus Capital Management's BIVI Position: Q4 2023 in Review

Long Focus Capital Management sold out of BioVie (BIVI) in Q4 2023, closing a stake of 200 shares — an estimated $68.2K sold.

Long Focus Capital Management first reported a position in BIVI in Q4 2021 and held it in 8 quarters. The position peaked at $162K in Q1 2023. 53 funds tracked by Wall St. Rank hold BIVI as of Q4 2023.

Long Focus Capital Management reported no remaining BioVie position as of Q4 2023 after selling out during the quarter.
Long Focus Capital Management sold 200 BioVie shares in Q4 2023, an estimated $68.2K.
Long Focus Capital Management first reported a position in BioVie in Q4 2021 and held it in 8 quarters.
Long Focus Capital Management's BioVie position peaked at $162K in Q1 2023.
53 funds tracked by Wall St. Rank held BioVie as of Q4 2023.

Based on Long Focus Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.